Island Pharmaceuticals LtdASX: ILA

ILA submits IND to US FDA for Phase 2a PEACH clinical trial

Dec 28, 2022 at 3:29 AM UTC · Issued by Island Pharmaceuticals Ltd

Island Pharmaceuticals Ltd has released a press release.

View Attachment